WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


City of Branson Orders Shutdown of Motel Property
North Arkansas College Recognized for Nursing Program
Jamaican Illegally Residing in Branson Sentenced on Firearm Charges
Investigation Underway After Body Discovered in Hollister